Upgrade to SI Premium - Free Trial

Johnson & Johnson (JNJ) PT Raised to $255 at Barclays

April 15, 2026 5:57 AM
Barclays analyst Matt Miksic raised the price target on Johnson & Johnson (NYSE: JNJ) to $255.00 (from $234.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change